Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
Get the latest NAV of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹174.63
1D
NAV as on 31 Jul 2025
19.77%/per year
Since Inception
▲▼
70 people have invested ₹ 1L in Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl in the last three months
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Performance vs. Nifty 500
Fund returns vs Benchmark returns vs Category Average returns as on (31-Jul-25)
The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.
Peer comparison
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Returns Calculator
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Asset Allocation
See fund asset allocation details as on (14-Jul-25)
Fund Distribution
as on (14-Jul-25)
Equity 99.5%
Debt & Cash 0.5%
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Sector Allocation
See fund sector allocation details as on (14-Jul-25)
Sector Allocation
Equity 99.5%
Debt & Cash 0.5%
Top Sector in June was Health
Health
100%
Health
100%
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Holdings Details
as on (30-Jun-25)
Equity
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Overview
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
| Expense ratio | 0.89% |
Benchmark | BSE Healthcare TR INR |
| AUM | ₹8569 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 14.27% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
About Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Kinjal Desai, Sailesh Raj Bhan. The fund could potentially beat inflation in the long-run.
Key Parameters
- Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl has ₹8569 Cr worth of assets under management (AUM) as on Jul 2025 and is more than category average.
- The fund has an expense ratio 0.9.
Returns
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl has given a CAGR return of 19.77% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 8.66%, 25.18% and 23.32% respectively.
Holdings
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Lupin Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl has no lock in period.
Fund Manager
Kinjal Desai
Fund Manager of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl, since 25 May 2018
Sailesh Raj Bhan
Fund Manager of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl, since 1 April 2005
- AUM of the fund stands at 8.6K Cr as of Jun'25
- AUM increased by 217 Cr between Jun'25 and May'25
More funds from Nippon
5Y CAGR
▲ 32.65
5Y CAGR
▲ 37.30
3Y CAGR
▲ 25.84
5Y CAGR
▲ 32.80
Frequently Asked Questions for Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
How do I invest in Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
- Download the INDmoney app.
- Search for ‘Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl’.
- Select whether you want to invest in SIP or lump sum.
- Enter the amount you wish to invest.
- Set up payments via bank mandate or UPI.